Form 4: Dexcom Director Transfers Shares to Family Trust
SEC Form 4 Filing
Director Steven R. Altman transferred 2,885 shares of Dexcom Inc. common stock from direct ownership to the Altman Family Trust on May 18, 2024.
Summary
- On May 18, 2024, Steven R. Altman, a director of Dexcom Inc., transferred 2,885 shares of common stock to the Steven R. and Lisa J. Altman, TTEE's Altman Family Trust DTD 8/21/92.
- The transfer occurred upon the vesting of previously awarded restricted stock units.
- The reporting person is a trustee of the Altman Family Trust.
- Following the transaction, the Altman Family Trust holds 56,017 shares of Dexcom Inc. common stock.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing a share transfer to a family trust, indicating a neutral sentiment.
Industry Context
This is a routine disclosure related to insider transactions and doesn't necessarily reflect a change in the company's outlook or performance.
Stakeholder Impact
- The transaction has minimal impact on stakeholders as it is a transfer of shares to a family trust and does not represent a sale on the open market.
Key Dates
| Date | Description |
|---|---|
| 08/21/1992 | Date of the Altman Family Trust (DTD) |
| 05/18/2024 | Date of the share transfer transaction |
| 05/21/2024 | Date of signature on the Form 4 |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.